Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Centre for Addiction and Mental Health |
---|---|
Information provided by: | Centre for Addiction and Mental Health |
ClinicalTrials.gov Identifier: | NCT00832845 |
Schizophrenia is associated with significant cognitive and functional deficits. As patients with schizophrenia grow older, the impact of these deficits at a personal and public health level is likely to increase. Cognitive Behavioral and Social Skills Training (CBSST) is a recently developed group therapy that increased the frequency of social activities among middle-aged patients with schizophrenia. It also increased cognitive insight, a measure of the ability to reduce confidence in aberrant beliefs. To date, CBSST has not been studied in late-life schizophrenia. In addition, its impact on medications management, an instrumental function that is particularly salient in late life, and its interactions with cognition are largely unknown.
Thus, we propose to study the efficacy of CBSST in improving social skills and medications management in patients with late-life schizophrenia, and to study the interactions between the patients' cognitive characteristics and their response to CBSST.
Condition | Intervention |
---|---|
Schizophrenia |
Behavioral: Cognitive Behavioral Social Skills Training (CBSST) plus treatment as usual Behavioral: Treatment as usual (TAU) |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment, Efficacy Study |
Official Title: | Cognitive Behavioral Social Skills Training for Patients With Late-LIfe Schizophrenia: a Pilot Study |
Estimated Enrollment: | 40 |
Study Start Date: | June 2008 |
Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Behavioral: Cognitive Behavioral Social Skills Training (CBSST) plus treatment as usual
Patients will receive CBSST in addition to their regular treatment for 24 weeks.
|
2: Active Comparator |
Behavioral: Treatment as usual (TAU)
Patients will receive their regular treatment for 24 weeks without CBSST. TAU consists of the standard care that patients receive, including routine visits and contacts with their physicians and clinicians. However, in addition to the standard of care, subjects receiving TAU will have 24 weekly 60-minute non-structured meetings, including half-hour lunch break, to control for non-specific factors associated with group therapy.
|
Ages Eligible for Study: | 60 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: David C. Mamo, MD, MSc | 416-535-8501 ext 7532 | David_Mamo@camh.net |
Canada, Ontario | |
Centre for Addiction and Mental Health | Recruiting |
Toronto, Ontario, Canada, M6J 1H4 | |
Contact: David C. Mamo, MD MSc 416-535-8501 ext 7532 David_Mamo@camh.net | |
Principal Investigator: David C. Mamo, MD, MSc | |
Sub-Investigator: Benoit H. Mulsant, MD, MSc | |
Sub-Investigator: Bruce G. Pollock, MD, PhD | |
Sub-Investigator: Tarek K. Rajji, MD |
Principal Investigator: | David C. Mamo, MD, MSc | Centre for Addiction and Mental Health |
Responsible Party: | Centre for Addiction and Mental Health ( David Mamo, MD MSc ) |
Study ID Numbers: | 066/2008 |
Study First Received: | January 29, 2009 |
Last Updated: | January 29, 2009 |
ClinicalTrials.gov Identifier: | NCT00832845 History of Changes |
Health Authority: | Canada: Health Canada |
Late-life schizophrenia (LLS) Cognitive Behavioural Social Skills Training (CBSST) Randomized |
Schizophrenia Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |
Schizophrenia Mental Disorders Schizophrenia and Disorders with Psychotic Features |